Reckitt Benckiser Group Plc reported weaker-than-expected sales on sluggish demand for its cold medicines in the US and as the conflict in the Middle East hit supplies in the region.
Reckitt’s Sales Weighed Down by Cold Drugs, Iran War Fallout
Jillian Deutsch·Bloomberg Markets··1 min readLimited
B
Continue reading on Bloomberg Markets
This article was sourced from Bloomberg Markets's RSS feed. Visit the original for the complete story.
Limited free access — this source offers metered access before requiring a subscription.